Loading company…
New York-based biotech developing therapies by studying the genes of people with exceptional health traits.
Variant Bio Inc. was founded in 2018 in New York, US, and develops therapies informed by human genetics. It analyzes genes from people with exceptional health traits to identify the molecular basis of disease, and works with academic institutions and healthcare providers on research and partnerships. The company has completed three deals, most recently USD 50.00 mn from Novo Nordisk on January 7, 2025. Andrew Farnum is CEO, and Kaja Wasik and Stephane Castel are founders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in